Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that m ...
On the evening of Thursday, March 18, a group of Scott City High School students attended the program "Navigating the Hemispheres of Neuroscience" presented by Scott R. Gibbs, MD, FACS and hosted by ...
Reunion Neuroscience, Inc., a clinical-stage biopharmaceutical company committed to revolutionizing the treatment of underserved mental health disorders through the advancement of next-generation ...
As the 2026 semester progresses, psychology and neuroscience students face a dual challenge: mastering the nuanced updates in APA 7th edition and MLA 9th edition citation styles while creating ...
Results Show Continued Safety, Tolerability, and Sustained Clinical Benefit Including Improvements in Function, Physician- and Patient-Reported Outcomes, and Quality-of-Life This Personalized ...
WALTHAM, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sironax, a global clinical-stage biotechnology company dedicated to discovering and developing transformative therapies for age-related degenerative ...
Patients with implanted neural devices offer researchers unique opportunities to study the basic workings of the human brain. This is made possible by patients undergoing epilepsy monitoring or the ...
A new synthesis of psychological phenomena, neuroscience, and authentic delivery offers fresh insights for public speakers and event organizers. Drawing on examples from crowd-sourced discussions, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results